VX15/2503
VX15/2503-N-131
Phase 2 small_molecule completed
Quick answer
VX15/2503 for Huntington's Disease is a Phase 2 program (small_molecule) at VACCINEX, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- VACCINEX, INC.
- Indication
- Huntington's Disease
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed